Ancillary Reagents Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
Ancillary Reagents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product Type (Buffers, Diluents, Solvents, Enzymes, Stains & Dyes, Others), By Application (Clinical Diagnostics, Drug Discovery & Development, Immunology, Molecular Biology, Genomics & Proteomics, Microbiology, Others), By End User (Hospitals & Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Research Institutions, Contract Research Organizations, Others), By Region & Competition, 2021-2031F
報告摘要
Market Overview
The Global Ancillary Reagents Market is projected to expand significantly, rising from USD 11.38 Billion in 2025 to USD 17.38 Billion by 2031, demonstrating a 7.31% CAGR. This market encompasses essential raw materials like cytokines, enzymes, and buffers, which are critical for the manufacturing of cell and gene therapies but are not intended to remain in the final product. The primary drivers include the rapid expansion of the biopharmaceutical development pipeline, with over 3,000 therapies currently in development, and the transition of advanced therapies from clinical research to commercial production, necessitating consistent supplies of compliant, GMP-grade reagents. However, a significant challenge impeding broader market expansion is the lack of harmonized global regulatory standards for raw materials, leading to complex supply chains and compliance burdens for manufacturers operating across different jurisdictions.
Market Driver
The exponential growth of the cell and gene therapy sector is the primary catalyst for the ancillary reagents market, demanding specialized, GMP-grade inputs for processes like cell isolation, activation, and expansion. This demand is intensified by a robust pipeline of over 3,200 therapies progressing through clinical phases, requiring scalable and consistent reagent supplies to meet strict safety standards. Furthermore, surging global production of biopharmaceuticals and biosimilars accelerates market momentum, driving the need for high-quality buffer solutions and process consumables in large-scale commercial manufacturing. As manufacturers expand capacity and new drugs gain approval, the reliance on validated ancillary materials becomes critical to ensure batch consistency and regulatory compliance.
Market Challenge
The lack of harmonized global regulatory standards for raw materials presents a significant impediment to the growth of the Global Ancillary Reagents Market. As biopharmaceutical developers increasingly operate internationally, the absence of a unified regulatory framework forces reagent suppliers to navigate disparate compliance requirements across various jurisdictions. This regulatory fragmentation creates substantial supply chain complexities, as materials compliant in one region may require additional validation or documentation elsewhere. Consequently, manufacturers must dedicate considerable capital and technical resources to redundant compliance activities, which increases operational costs and extends lead times for critical inputs. This bottleneck is particularly acute as the industry scales from clinical development to commercial production, hindering the market's ability to efficiently meet surging demand for high-grade materials.
Market Trends
Two pivotal trends are currently reshaping the ancillary reagents landscape. Firstly, there is a growing integration with automated and closed-system manufacturing workflows, driven by the imperative to eliminate contamination risks and minimize human error in cell and gene therapy production. This trend necessitates reagents compatible with advanced processing equipment and robotic platforms to ensure seamless scalability and enhance batch consistency, with many life sciences professionals prioritizing digitalization and automation in their capital investments. Secondly, a pronounced focus on sustainable and eco-friendly reagent production practices is emerging, compelling suppliers to reduce their environmental footprint through initiatives like cutting single-use plastics and adopting carbon-neutral manufacturing. This shift towards greener supply chains and adherence to environmental, social, and governance (ESG) mandates is becoming critical for long-term viability and market competitiveness, as biopharma executives increasingly view sustainability failures as a significant organizational risk.
Key Market Players
* Thermo Fisher Scientific Inc.
* Merck KGaA
* Lonza Group Ltd.
* Bio-Rad Laboratories, Inc.
* Agilent Technologies, Inc.
* PerkinElmer, Inc.
* Qiagen N.V.
* Promega Corporation
* Sartorius AG
* Miltenyi Biotec B.V. & Co. KG
Report Scope
In this report, the Global Ancillary Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# Ancillary Reagents Market, By Product Type
* Buffers
* Diluents
* Solvents
* Enzymes
* Stains & Dyes
* Others
# Ancillary Reagents Market, By Application
* Clinical Diagnostics
* Drug Discovery & Development
* Immunology
* Molecular Biology
* Genomics & Proteomics
* Microbiology
* Others
# Ancillary Reagents Market, By End User
* Hospitals & Diagnostic Laboratories
* Pharmaceutical and Biotechnology Companies
* Research Institutions
* Contract Research Organizations
* Others
# Ancillary Reagents Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Ancillary Reagents Market.
Available Customizations:
Global Ancillary Reagents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Ancillary Reagents Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Buffers, Diluents, Solvents, Enzymes, Stains & Dyes, Others)
5.2.2. By Application (Clinical Diagnostics, Drug Discovery & Development, Immunology, Molecular Biology, Genomics & Proteomics, Microbiology, Others)
5.2.3. By End User (Hospitals & Diagnostic Laboratories, Pharmaceutical and Biotechnology Companies, Research Institutions, Contract Research Organizations, Others)
5.2.4. By Region
5.2.5. By Company (2025)
5.3. Market Map
6. North America Ancillary Reagents Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Application
6.2.3. By End User
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Ancillary Reagents Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product Type
6.3.1.2.2. By Application
6.3.1.2.3. By End User
6.3.2. Canada Ancillary Reagents Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product Type
6.3.2.2.2. By Application
6.3.2.2.3. By End User
6.3.3. Mexico Ancillary Reagents Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product Type
6.3.3.2.2. By Application
6.3.3.2.3. By End User
7. Europe Ancillary Reagents Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Ancillary Reagents Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product Type
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. France Ancillary Reagents Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product Type
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. United Kingdom Ancillary Reagents Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product Type
7.3.3.2.2. By Application
7.3.3.2.3. By End User
7.3.4. Italy Ancillary Reagents Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product Type
7.3.4.2.2. By Application
7.3.4.2.3. By End User
7.3.5. Spain Ancillary Reagents Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product Type
7.3.5.2.2. By Application
7.3.5.2.3. By End User
8. Asia Pacific Ancillary Reagents Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Ancillary Reagents Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product Type
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. India Ancillary Reagents Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product Type
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. Japan Ancillary Reagents Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product Type
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. South Korea Ancillary Reagents Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product Type
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Australia Ancillary Reagents Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product Type
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. Middle East & Africa Ancillary Reagents Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Ancillary Reagents Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product Type
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. UAE Ancillary Reagents Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product Type
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. South Africa Ancillary Reagents Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product Type
9.3.3.2.2. By Application
9.3.3.2.3. By End User
10. South America Ancillary Reagents Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product Type
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Ancillary Reagents Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product Type
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Colombia Ancillary Reagents Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product Type
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. Argentina Ancillary Reagents Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product Type
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Ancillary Reagents Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Thermo Fisher Scientific Inc.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Merck KGaA
15.3. Lonza Group Ltd.
15.4. Bio-Rad Laboratories, Inc.
15.5. Agilent Technologies, Inc.
15.6. PerkinElmer, Inc.
15.7. Qiagen N.V.
15.8. Promega Corporation
15.9. Sartorius AG
15.10. Miltenyi Biotec B.V. & Co. KG
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們